274 related articles for article (PubMed ID: 30196109)
1. Farnesoid X receptor agonist obeticholic acid inhibits renal inflammation and oxidative stress during lipopolysaccharide-induced acute kidney injury.
Zhu JB; Xu S; Li J; Song J; Luo B; Song YP; Zhang ZH; Chen YH; Xie DD; Yu DX; Xu DX
Eur J Pharmacol; 2018 Nov; 838():60-68. PubMed ID: 30196109
[TBL] [Abstract][Full Text] [Related]
2. Obeticholic Acid Protects against Lipopolysaccharide-Induced Fetal Death and Intrauterine Growth Restriction through Its Anti-Inflammatory Activity.
Chen YH; Hu XG; Zhou Y; Yu Z; Fu L; Zhang GB; Bo QL; Wang H; Zhang C; Xu DX
J Immunol; 2016 Dec; 197(12):4762-4770. PubMed ID: 27821667
[TBL] [Abstract][Full Text] [Related]
3. Obeticholic acid alleviate lipopolysaccharide-induced acute lung injury via its anti-inflammatory effects in mice.
Fei J; Fu L; Hu B; Chen YH; Zhao H; Xu DX; Li JB
Int Immunopharmacol; 2019 Jan; 66():177-184. PubMed ID: 30468885
[TBL] [Abstract][Full Text] [Related]
4. Obeticholic acid protects against carbon tetrachloride-induced acute liver injury and inflammation.
Zhang DG; Zhang C; Wang JX; Wang BW; Wang H; Zhang ZH; Chen YH; Lu Y; Tao L; Wang JQ; Chen X; Xu DX
Toxicol Appl Pharmacol; 2017 Jan; 314():39-47. PubMed ID: 27865854
[TBL] [Abstract][Full Text] [Related]
5. Obeticholic acid differentially regulates hepatic injury and inflammation at different stages of D-galactosamine/lipopolysaccharide-evoked acute liver failure.
Ding W; Fan YY; Zhang C; Fu L; Chen X; Xu DX
Eur J Pharmacol; 2019 May; 850():150-157. PubMed ID: 30772394
[TBL] [Abstract][Full Text] [Related]
6. Obeticholic acid protects mice against lipopolysaccharide-induced liver injury and inflammation.
Xiong X; Ren Y; Cui Y; Li R; Wang C; Zhang Y
Biomed Pharmacother; 2017 Dec; 96():1292-1298. PubMed ID: 29174575
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D3 pretreatment alleviates renal oxidative stress in lipopolysaccharide-induced acute kidney injury.
Xu S; Chen YH; Tan ZX; Xie DD; Zhang C; Xia MZ; Wang H; Zhao H; Xu DX; Yu DX
J Steroid Biochem Mol Biol; 2015 Aug; 152():133-41. PubMed ID: 26013770
[TBL] [Abstract][Full Text] [Related]
8. Obeticholic acid protects against diabetic cardiomyopathy by activation of FXR/Nrf2 signaling in db/db mice.
Wu H; Liu G; He Y; Da J; Xie B
Eur J Pharmacol; 2019 Sep; 858():172393. PubMed ID: 31085240
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D3 pretreatment regulates renal inflammatory responses during lipopolysaccharide-induced acute kidney injury.
Xu S; Chen YH; Tan ZX; Xie DD; Zhang C; Zhang ZH; Wang H; Zhao H; Yu DX; Xu DX
Sci Rep; 2015 Dec; 5():18687. PubMed ID: 26691774
[TBL] [Abstract][Full Text] [Related]
10. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W
Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375
[TBL] [Abstract][Full Text] [Related]
11. Effect of chenodeoxycholic acid on fibrosis, inflammation and oxidative stress in kidney in high-fructose-fed Wistar rats.
Hu Z; Ren L; Wang C; Liu B; Song G
Kidney Blood Press Res; 2012; 36(1):85-97. PubMed ID: 22948014
[TBL] [Abstract][Full Text] [Related]
12. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.
Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corcetto F; Corno C; Maneschi E; Pini A; Adorini L; Vannelli GB; Maggi M; Vignozzi L
J Steroid Biochem Mol Biol; 2017 Apr; 168():26-37. PubMed ID: 28115235
[TBL] [Abstract][Full Text] [Related]
13. Obeticholic acid prevents carbon tetrachloride-induced liver fibrosis through interaction between farnesoid X receptor and Smad3.
Fan YY; Ding W; Zhang C; Fu L; Xu DX; Chen X
Int Immunopharmacol; 2019 Dec; 77():105911. PubMed ID: 31671330
[TBL] [Abstract][Full Text] [Related]
14. Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension.
Vignozzi L; Morelli A; Cellai I; Filippi S; Comeglio P; Sarchielli E; Maneschi E; Vannelli GB; Adorini L; Maggi M
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):277-292. PubMed ID: 27425465
[TBL] [Abstract][Full Text] [Related]
15. Obeticholic acid ameliorates hepatorenal syndrome in ascitic cirrhotic rats by down-regulating the renal 8-iso-PGF2α-activated COX-TXA2 pathway.
Tsai YL; Liu CW; Hsu CF; Huang CC; Lin MW; Huang SF; Li TH; Lee KC; Hsieh YC; Yang YY; Lee TY; Liu HM; Huang YH; Hou MC; Lin HC
Clin Sci (Lond); 2020 Aug; 134(15):2055-2073. PubMed ID: 32725149
[TBL] [Abstract][Full Text] [Related]
16. Obeticholic Acid Ameliorates Valproic Acid-Induced Hepatic Steatosis and Oxidative Stress.
Gai Z; Krajnc E; Samodelov SL; Visentin M; Kullak-Ublick GA
Mol Pharmacol; 2020 May; 97(5):314-323. PubMed ID: 32098797
[TBL] [Abstract][Full Text] [Related]
17. Obeticholic Acid Protects against Gestational Cholestasis-Induced Fetal Intrauterine Growth Restriction in Mice.
Chen W; Gao XX; Ma L; Liu ZB; Li L; Wang H; Gao L; Xu DX; Chen YH
Oxid Med Cell Longev; 2019; 2019():7419249. PubMed ID: 31827696
[TBL] [Abstract][Full Text] [Related]
18. Farnesoid X Receptor Activation Attenuates Intestinal Ischemia Reperfusion Injury in Rats.
Ceulemans LJ; Verbeke L; Decuypere JP; Farré R; De Hertogh G; Lenaerts K; Jochmans I; Monbaliu D; Nevens F; Tack J; Laleman W; Pirenne J
PLoS One; 2017; 12(1):e0169331. PubMed ID: 28060943
[TBL] [Abstract][Full Text] [Related]
19. Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice.
Gai Z; Gui T; Hiller C; Kullak-Ublick GA
J Biol Chem; 2016 Jan; 291(5):2397-411. PubMed ID: 26655953
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model.
Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corno C; Adorini L; Vannelli GB; Maggi M; Vignozzi L
J Endocrinol Invest; 2019 Aug; 42(8):951-965. PubMed ID: 30674010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
